PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Pediatrics10.3345/cep.2020.019842022653108-114Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in KoreaByung Ok Kwak, Young Jin Hong, Dong Hyun Kimhttp://e-cep.org/upload/pdf/cep-2020-01984.pdf, http://e-cep.org/journal/view.php?doi=10.3345/cep.2020.01984, http://e-cep.org/upload/pdf/cep-2020-01984.pdf
Vaccine10.1016/0264-410x(91)90298-k1991910772Therapy, diagnosis and vaccine for Japanese-encephalitis virus; comprising recombinant Japanese-encephalitis virus envelope protein expressed in insect cell culture; recombinant vaccinehttps://api.elsevier.com/content/article/PII:0264410X9190298K?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X9190298K?httpAccept=text/plain
Vaccine10.1016/0264-410x(93)90087-e199311111168Recombinant chimeric flavivirus; tick-borne encephalitis virus, dengue virus, yellow-fever virus or Japanese-encephalitis virus recombinant vaccinehttps://api.elsevier.com/content/article/PII:0264410X9390087E?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X9390087E?httpAccept=text/plain
Vaccine10.1016/s0264-410x(97)87733-x19971591045Infectious Japanese-encephalitis virus cDNA clone producing a highly attenuated recombinant Japanese-encephalitis virus and its vaccine; mutant virus IC47 production by point mutation for use as a recombinant vaccinehttps://api.elsevier.com/content/article/PII:S0264410X9787733X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X9787733X?httpAccept=text/plain
Vaccine10.1016/s0264-410x(00)00041-420001833-35Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strainsI Kurane, T Takasakihttps://api.elsevier.com/content/article/PII:S0264410X00000414?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X00000414?httpAccept=text/plain
Vaccine10.1016/0264-410x(87)90059-4198752128-132Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virusY OKUNO, Y OKAMOTO, A YAMADA, K BABA, H YABUUCHIhttps://api.elsevier.com/content/article/PII:0264410X87900594?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0264410X87900594?httpAccept=text/plain
Vaccine10.1016/s0264-410x(00)00144-42000192-3155-157Evaluation of the potency of BIKEN inactivated Japanese Encephalitis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge modelM.S Ashok, P.N Rangarajanhttps://api.elsevier.com/content/article/PII:S0264410X00001444?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X00001444?httpAccept=text/plain
Reactions Weekly10.1007/s40278-015-5933-4201515711143-143Japanese encephalitis vaccinehttp://link.springer.com/content/pdf/10.1007/s40278-015-5933-4.pdf, http://link.springer.com/article/10.1007/s40278-015-5933-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-015-5933-4
Vaccine10.1016/j.vaccine.2007.11.0672008265589-594Single dose of inactivated Japanese encephalitis vaccine with poly(γ-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virusShigefumi Okamoto, Hironori Yoshii, Toyokazu Ishikawa, Takami Akagi, Mitsuru Akashi, Michiaki Takahashi, Koichi Yamanishi, Yasuko Morihttps://api.elsevier.com/content/article/PII:S0264410X07013837?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X07013837?httpAccept=text/plain
Vaccine10.1016/j.vaccine.2007.10.047200726115-23Phenotypic changes in the Japanese encephalitis virus after one passage in Neuro-2a cells: Generation of attenuated strains of the virusShyan-Song Chiou, Wei-June Chenhttps://api.elsevier.com/content/article/PII:S0264410X07012315?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0264410X07012315?httpAccept=text/plain